Fundamental virology: viral structure, replicative cycle, cellular tropism
A virus is a biomolecular assembly with two major components: an envelope carrying surface glycoproteins (the molecular “key”), and a genetic payload (DNA or RNA) protected inside. Viruses are not autonomous living organisms — they are obligate parasites that require a host cell’s biomolecular factory to replicate.
SARS-CoV-2, the causative agent of COVID-19, is a single-stranded positive-sense RNA virus of approximately 120 nm in diameter. Its characteristic crown of Spike proteins gives the coronavirus family its name.
Surface glycoproteins act as molecular keys that bind to specific receptors on host cells — a lock-and-key mechanism with high molecular affinity. Once bound, the virus injects its genetic payload into the cell. For SARS-CoV-2, this key is the Spike protein targeting the ACE2 receptor.
Blocking this anchor — either by targeting the viral key or saturating the cellular lock — constitutes one class of therapeutic strategies, though care must be taken not to disrupt normal intercellular signaling mediated through the same receptors.
In normal cellular operations, DNA is transcribed into messenger RNA by RNA polymerase, then translated into proteins by ribosomes. As a positive-sense RNA virus, SARS-CoV-2 bypasses the need for reverse transcription: its genome functions directly as mRNA upon entering the cytoplasm, immediately commandeering the host cell’s ribosomes to produce viral proteins — including the viral RNA-dependent RNA polymerase (RdRp) that replicates the viral genome.
This distinction is therapeutically critical: drugs like Remdesivir target the viral RdRp (not reverse transcriptase), causing premature termination of RNA synthesis.
RNA viruses exhibit higher mutation rates than DNA viruses for three reasons: RNA polymerases lack proofreading capabilities, single-stranded RNA has no backup strand for error correction, and the reverse transcription step (in true retroviruses) stabilizes mutations.
However, mutation is always a stochastic event — the virus does not “decide” to become more dangerous. Some mutations may even extinguish the virus’s ability to infect human cells, ending the pandemic.
Coronaviruses are capable of genetic recombination when two viral genomes coexist in the same host cell. A damaged region of one virus’s RNA can be replaced by a functional region from another coronavirus — potentially swapping the Spike protein that determines host specificity.
SARS-CoV-2 may have emerged through such recombination in an intermediate animal host, combining the pathogenic capabilities of a bat coronavirus with a Spike protein capable of binding human ACE2 receptors — the butterfly effect of a molecular event creating a global pandemic.